A detailed history of Pro Share Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Pro Share Advisors LLC holds 1,568,644 shares of JNJ stock, worth $243 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
1,568,644
Previous 1,651,733 5.03%
Holding current value
$243 Million
Previous $241 Million 5.3%
% of portfolio
0.64%
Previous 0.66%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $12.1 Million - $13.9 Million
-83,089 Reduced 5.03%
1,568,644 $254 Million
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $21.3 Million - $23.3 Million
147,609 Added 9.81%
1,651,733 $241 Million
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $3 Million - $3.15 Million
-19,340 Reduced 1.27%
1,504,124 $238 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $5.01 Million - $5.47 Million
34,441 Added 2.31%
1,523,464 $239 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $21.8 Million - $24.4 Million
-139,829 Reduced 8.58%
1,489,023 $232 Million
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $4.48 Million - $4.82 Million
29,046 Added 1.82%
1,628,852 $270 Million
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $16 Million - $19.1 Million
105,743 Added 7.08%
1,599,806 $248 Million
Q4 2022

Feb 02, 2023

BUY
$160.2 - $179.79 $7.67 Million - $8.6 Million
47,848 Added 3.31%
1,494,063 $264 Million
Q3 2022

Nov 04, 2022

SELL
$161.33 - $179.52 $6.51 Million - $7.24 Million
-40,329 Reduced 2.71%
1,446,215 $236 Million
Q2 2022

Aug 01, 2022

SELL
$168.19 - $186.01 $43.8 Million - $48.5 Million
-260,701 Reduced 14.92%
1,486,544 $264 Million
Q1 2022

May 10, 2022

BUY
$158.14 - $179.59 $3.81 Million - $4.33 Million
24,086 Added 1.4%
1,747,245 $310 Million
Q4 2021

Feb 08, 2022

BUY
$155.93 - $173.01 $38.4 Million - $42.6 Million
246,180 Added 16.67%
1,723,159 $295 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $2.27 Million - $2.52 Million
14,065 Added 0.96%
1,476,979 $239 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $30.4 Million - $32.7 Million
190,872 Added 15.01%
1,462,914 $241 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $6.02 Million - $6.7 Million
39,311 Added 3.19%
1,272,042 $209 Million
Q4 2020

Feb 09, 2021

BUY
$137.11 - $157.38 $12.3 Million - $14.1 Million
89,803 Added 7.86%
1,232,731 $194 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $9.65 Million - $10.6 Million
68,753 Added 6.4%
1,142,928 $170 Million
Q2 2020

Aug 03, 2020

SELL
$128.81 - $155.51 $11.5 Million - $13.8 Million
-89,021 Reduced 7.65%
1,074,175 $151 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $40.1 Million - $55.6 Million
-361,212 Reduced 23.7%
1,163,196 $153 Million
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $30.7 Million - $35.3 Million
240,999 Added 18.78%
1,524,408 $222 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $18.6 Million - $20.8 Million
146,614 Added 12.9%
1,283,409 $166 Million
Q2 2019

Aug 13, 2019

SELL
$131.15 - $144.24 $10.4 Million - $11.4 Million
-79,213 Reduced 6.51%
1,136,795 $158 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $9.23 Million - $10.3 Million
73,448 Added 6.43%
1,216,008 $170 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $9.54 Million - $11.5 Million
77,627 Added 7.29%
1,142,560 $147 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $12.6 Million - $14.8 Million
-103,593 Reduced 8.87%
1,064,933 $147 Million
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $6.54 Million - $7.22 Million
-54,799 Reduced 4.48%
1,168,526 $142 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $9.03 Million - $10.7 Million
72,166 Added 6.27%
1,223,325 $157 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $34.5 Million - $37.8 Million
263,287 Added 29.65%
1,151,159 $161 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $2.84 Million - $2.97 Million
21,963 Added 2.54%
887,872 $115 Million
Q2 2017

Aug 11, 2017

BUY
N/A
865,909
865,909 $115 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.